Display Settings:

Format

Send to:

Choose Destination
    Arch Neurol. 1975 Aug;32(8):535-8.

    Phenytoin and membrane fluidity in myotonic dystrophy.

    Abstract

    Electron spin resonance spectroscopy was used to substantiate the presence of a membrane defect in myotonic erythrocytes. There was increased membrane fluidity and decreased polarity in myotonic membranes. Phenytoin (formerly diphenylhydantoin) "normalizes" fluidity differences in spectra derived from myotonic erythrocytes but has no significant effect on normal spectra. These experiments demonstrate the applicability of biophysical methods to human erythrocyte membranes and support the concept of a membrane defect in myotonic dystrophy that does not have a primary myopathic, neuropathic, or vascular cause.

    PMID:
    168843
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Silverchair Information Systems

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk